Orphan Drug Consulting supports new and emerging pharmaceutical companies to launch products globally from an EU and US location. We offer end-to-end support as you navigate your way through legislation across supply chain, quality assurance, regulatory, tax and customs rules to support your business in launching as quickly and smoothly as possible. Orphan Drug Consulting brings many years of supply chain and quality assurance experience to assist your organisation in bringing a product from clinical to commercial launch, specialising in Orphan Drug launch. By utilising specific allowances and reimbursement programs open to Orphan Drugs in different countries to optimise supply, your product can be on the market quickly with production runs and SKU’s for small patient populations kept to a minimum.